The James Group Newsletter Vol. 6, Num. 6: Health Insurance Subsidy Funding, Health Care: Just Fix It!, Surprise Medical Bills, CVS Mounts Defense of Aetna Deal, For-Profit Stem Cell Company, Humana: Centene, FDA: Unapproved CA Drugs for Pts, Quest Diagnostics Breach, Newer Drugs Improving Some Forms of Cancer, States Sue Opioid Maker of Deception, 41 New Cases of Measles, Nontoxic Protective Methods: Mosquitos and Ticks
The James Group Newsletter Vol. 6, Num. 5: Medicare For All, Drug Pricing Bill, Single Payer HC, CVS: New Service, Medicaid Expansion, Surprise Med Bills, 3D Mammography, Insulin Prices, Exercise Affects Memory, FB Health Data, FDA: Sleep Aids, Measles Cases
The James Group Newsletter Vol. 5, Num. 15: 2019 OE Falls Slightly, TX Judge: ACA is Invalid, ACA: What Happens Now?, CVS and Aetna, Booker Seeks Medicaid Transparency, Alexander Will Not Seek Reelection, Health Ins on Demand?, Vaping Teens, Cigna Predictions of Opioid Abuse, US: 'Biologic' Drugs, 182K VA Enrolled in New Health Coverage, More Pets, Fewer Allergies, 2018: Health & Meds
The James Group Newsletter Vol. 6, Num. 4: Express Scripts, House Votes Rebuked, $40M Taxpayer Buyout, Surprise Medical Bills, AR Vote to Keep Medicaid Plan, Medicaid Expansion, Walgreens Lowers 2019 Expectations, US Borrowed $88B for HC in 2018, Robotics Gives Mobility to Disabled Children, Don't Forget Sunscreen Around Eyes, Seizure Risk: E-Cigs, Stem Cell Research, Health Plans Use of Medicare on Hospital Bills
The James Group Newsletter Vol. 5, Num. 14: Blue House, Red Senate, HC Top Issue for Voters, Cheap Health Plans Not Built for All, Montana & Medicaid, Medicare Expands to In-Home Supp, ID NE & UT Vote for Medicaid Expansion, Abortion Rights, HHS Opt Out of BC Mandate, IV Painkiller Alternative, Future of CVS, Possible Universal Flu Vaccine
The James Group Newsletter Vol. 6, Num. 3: Medicare For All Loses Momentum, CVS Names CIO, TX Takes Aim at Med Bills, J&J Research, Medicare Payments to Hospitals, New Alzheimer's Genes, MO: Abortion Restrictions, Measles Continue to Climb, Pharma CEOs Testify Before Congress, Trans Fat Bans, Costs of Stress-Out Workers
The James Group Newsletter Vol. 5, Num. 13: Drug Spending vs. Medicaid, Rising HC Bills, If Docs Got Paid Only Medicare Rates, Broad Spending Bill, Easing Costs on Drug Comps, Protect Against Surprise Med Bills, Life Insurance Incentives, Merger Cleared..
The James Group Newsletter Vol. 6, Num. 2: UT Plan for Medicaid Expansion, 'Medicare For All', Medicare Adv Plan, Measles Outbreak, MS Abortion Bill, Counseling for Mothers, CVS HC Services, MD Payment Ins Plan, FDA and Supplements, Youth Vaping, Immunotherapy
The James Group Newsletter Vol. 5, Num. 12: Pre-Ex Take Center Stage, Drug Cost Effects, Uninsured Rates Steady, Non-opioid pain meds, CA Gov Candidate Backs Universal HC, McCain's HC Legacy, Cigna-Express Scripts Approved, Senate Backs $854B Bill, MD
The James Group Newsletter Vol. 6, Num. 1: Shutdown Breaks Record, Birth Control Mandate, Remodel Medicaid, Hospitals Post Rx Prices, Flu Sickened 7M, TN Scientist, Americans Took 26T Steps in 2018, Real Pain Measurements, Rx Prices Take Center Stage....